#50 - Suing the FDA: GLP-1 Makers Using Chevron Ruling to Take On the FDA?

For the 50th episode of the Alumni Ventures' Tech Optimist podcast, Mike Collins and Mike Perry dive into three groundbreaking topics that are shaping our present and future. First, they tackle the contentious issue of litigation against the FDA, sparked by disagreements over drug classifications—a debate that could redefine pharmaceutical regulations. Next, the duo explores the role of AI in refining and implementing climate policies, highlighting its potential to sift through vast amounts of data to pinpoint effective strategies. Lastly, they address the complex relationship between technology and mental health, discussing both the challenges and opportunities it presents in combating loneliness and fostering connections. This milestone episode not only celebrates the past but also sets the stage for critical discussions on technology’s impact on society.

To Learn More:

Speakers:

Chapters:
  • (00:00) - Intro
  • (03:58) - Suing the FDA
  • (17:31) - AI analyzing climate policies
  • (25:13) - Is social media bad for your mental health?
  • (39:59) - Closing



Legal Disclosure:

Creators and Guests

Mike Collins
Host
Mike Collins
CEO and Co-Founder at Alumni Ventures
#50 - Suing the FDA: GLP-1 Makers Using Chevron Ruling to Take On the FDA?
Broadcast by